Prices delayed by at least 15 minutes | Print
British & American Investment Trust PLC
ORD SHS #1Open
8.00p
Previous close
8.00p
Trade high
6.00p
Estimated NAV
7.10
Year high
17.00p
Year low
6.00p
Premium / Discount
12.68%
Market capitalisation
£2.00 mn
Volume
425
Dividend yield
–
Ongoing charge
12%
ISIN
GB0000653112
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 08/12/2023 | 15/11/2024 |
| Ex-dividend date | 07/12/2023 | 14/11/2024 |
| Payment date | 21/12/2023 | 05/12/2024 |
| Amount | 1.75p | 1.75p |
Net asset value (NAV)
| Estimated NAV | 7.10 |
|---|---|
| Latest actual NAV | 7.10 |
| Latest actual NAV date | 30 October 2026 |
| 12m average premium/discount | 27.13% |
Top 10 holdings
| Holdings 30/06/2025 | % of assets |
|---|---|
| Geron Corp | 67.73 |
| Lineage Cell Therapeutics Inc | 0.98 |
| Relief Therapeutics (Switzerland) | 0.49 |
| Proteome Science | 0.18 |
| Northwest Biotherapeutics (Usa) | 0.06 |
| Sherborne Invs (Gurnsey) B (Unlisted) | 0.06 |
Investment objective
The policy is to invest predominantly in investment trusts and other leading UK and US-quoted companies to achieve a balance of income and growth.
Morningstar ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 16/11/2026 | 08:06:51 | 6 | 178 | 10.68 |
| 16/11/2026 | 08:06:46 | 6 | 247 | 14.82 |
| 13/11/2026 | 02:52:25 | 10 | 22 | 2.20 |
| 13/11/2026 | 02:36:20 | 10 | 247 | 24.70 |
| 13/11/2026 | 02:05:11 | 10 | 44 | 4.40 |